UK regulator adopts AI framework for medical devices and launches third AI Airlock phase
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that the UK government has adopted a set of recommendations on the use of artificial intelligence in medical devices. These recommendations were developed by an independent group of NHS doctors.
The adoption marks the first formal integration of the AI framework into the regulatory landscape, aiming to guide manufacturers on safety, performance and ethical considerations for AI‑driven health technologies.
The MHRA also said it is moving into the third phase of its AI Airlock, a regulatory sandbox that allows developers to test and refine AI products under supervised conditions before market entry.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Recon: BD pledges $19B US investment; McKesson, CD&R to buy Option Care for $5.8B”
read at raps ↗
comments(0)
5-min edit window · permanent after that